• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体(多蛋白酶复合物)在多种真核细胞中呈20 S环形颗粒状。

Proteasomes (multi-protease complexes) as 20 S ring-shaped particles in a variety of eukaryotic cells.

作者信息

Tanaka K, Yoshimura T, Kumatori A, Ichihara A, Ikai A, Nishigai M, Kameyama K, Takagi T

机构信息

Institute for Enzyme Research, University of Tokushima, Japan.

出版信息

J Biol Chem. 1988 Nov 5;263(31):16209-17.

PMID:3141402
Abstract

Latent multicatalytic protease complexes, named proteasomes, were purified to apparent homogeneity from various eukaryotic sources, such as human, rat, and chicken liver, Xenopus laevis ovary, and yeast (Saccharomyces cerevisiae), and their functional and structural properties were compared. They showed latency in breakdown of [methyl-3H]casein, but were greatly activated in various ways, such as by addition of polylysine. They all degraded three types of fluorogenic oligopeptides at the carboxyl side of basic, neutral, and acidic amino acids, and the three cleavage reactions showed different spectra for inhibition, suggesting that they had three distinct active sites. The proteasomes all seemed to be seryl endopeptidases with similar pH optima in the weakly alkaline region. Their physiochemical properties, such as their sedimentation coefficients (19 S to 22 S), diffusion coefficients (2.0-2.6 X 10(-7) cm2 s-1), molecular masses (700-900 kDa), and circular dichroic spectra, were similar. Their amino acid compositions were also very similar. Electron microscopy showed that they had similar well-defined symmetrical morphology, appearing to be ring-shaped particles with a small hole in the center. All the proteasomes seemed to be multisubunit complexes consisting of 15-20 polypeptides with molecular masses of 22-33 kDa and isoelectric points of pH 3-10, but they showed species-specific differences in subunit multiplicity. Moreover, they differed immunologically, as shown by Ouchterlony tests and immunoblotting analyses, although cross-immunoreactivities of some subunits or domains were observed. These results indicate that the sizes and shapes of these proteasomes have been highly conserved during evolution, but that they show species-specific differences in immunoreactivities and subunit structures. Thus proteasomes with similar structure and function seem to be ubiquitously distributed in eukaryotic organisms ranging from man to yeast. This distribution implies the general importance of these proteasomes for proteolysis.

摘要

从人、大鼠和鸡的肝脏、非洲爪蟾卵巢以及酵母(酿酒酵母)等多种真核生物来源中纯化出了潜在的多催化蛋白酶复合物,即蛋白酶体,并使其达到了表观均一性,同时对它们的功能和结构特性进行了比较。它们在分解[甲基-3H]酪蛋白时表现出潜伏性,但通过多种方式可被极大激活,比如添加多聚赖氨酸。它们都能在碱性、中性和酸性氨基酸的羧基侧降解三种类型的荧光寡肽,并且这三种切割反应呈现出不同的抑制谱,这表明它们具有三个不同的活性位点。这些蛋白酶体似乎都是丝氨酸内肽酶,在弱碱性区域具有相似的最适pH值。它们的物理化学性质,如沉降系数(19 S至22 S)、扩散系数(2.0 - 2.6×10⁻⁷ cm² s⁻¹)、分子量(700 - 900 kDa)以及圆二色光谱,都很相似。它们的氨基酸组成也非常相似。电子显微镜显示它们具有相似的明确对称形态,看起来是中心有小孔的环形颗粒。所有的蛋白酶体似乎都是由15 - 20种分子量为22 - 33 kDa且等电点为pH 3 - 10的多肽组成的多亚基复合物,但它们在亚基多样性上表现出物种特异性差异。此外,如免疫双扩散试验和免疫印迹分析所示,它们在免疫学上存在差异,尽管观察到了一些亚基或结构域的交叉免疫反应性。这些结果表明,这些蛋白酶体的大小和形状在进化过程中高度保守,但它们在免疫反应性和亚基结构上表现出物种特异性差异。因此,具有相似结构和功能的蛋白酶体似乎普遍存在于从人类到酵母的真核生物中。这种分布意味着这些蛋白酶体在蛋白水解中具有普遍重要性。

相似文献

1
Proteasomes (multi-protease complexes) as 20 S ring-shaped particles in a variety of eukaryotic cells.蛋白酶体(多蛋白酶复合物)在多种真核细胞中呈20 S环形颗粒状。
J Biol Chem. 1988 Nov 5;263(31):16209-17.
2
The 26S proteasome of the yeast Saccharomyces cerevisiae.酿酒酵母的26S蛋白酶体。
FEBS Lett. 1994 Nov 21;355(1):69-75. doi: 10.1016/0014-5793(94)01177-x.
3
Purification and characterization of the 26S proteasome complex catalyzing ATP-dependent breakdown of ubiquitin-ligated proteins from rat liver.大鼠肝脏中催化泛素连接蛋白ATP依赖性降解的26S蛋白酶体复合物的纯化与鉴定
J Biochem. 1993 Jun;113(6):754-68. doi: 10.1093/oxfordjournals.jbchem.a124116.
4
Tissue-specific expression of the subunits of chick 20S proteasomes.鸡20S蛋白酶体亚基的组织特异性表达。
Biochem Mol Biol Int. 1994 Mar;32(4):723-9.
5
Autodegradation of rat liver proteasomes (large multicatalytic proteinase complexes).大鼠肝脏蛋白酶体(大型多催化蛋白酶复合物)的自降解
Biochem Biophys Res Commun. 1989 Jan 31;158(2):548-54. doi: 10.1016/s0006-291x(89)80084-1.
6
Purification and characterization of proteasomes from Trypanosoma brucei.布氏锥虫蛋白酶体的纯化与特性分析
Mol Biochem Parasitol. 1996 Jun;78(1-2):33-46. doi: 10.1016/s0166-6851(96)02599-6.
7
Purification and characterization of the 26 S proteasome from spinach leaves.菠菜叶片26S蛋白酶体的纯化与特性分析
J Biol Chem. 1994 Oct 14;269(41):25905-10.
8
Isolation and characterization of two 20S proteasomes from the endoplasmic reticulum of rat liver microsomes.从大鼠肝脏微粒体内质网中分离并鉴定两种20S蛋白酶体。
J Biochem. 1999 Oct;126(4):722-30. doi: 10.1093/oxfordjournals.jbchem.a022509.
9
Purification and initial characterization of the proteasome from the higher plant Spinacia oleracea.高等植物菠菜蛋白酶体的纯化及初步表征
J Biol Chem. 1992 Oct 25;267(30):21678-84.
10
Proteasomes: protein and gene structures.蛋白酶体:蛋白质与基因结构
New Biol. 1992 Mar;4(3):173-87.

引用本文的文献

1
Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs.激活26S蛋白酶体以减轻蛋白毒性应激并提高PROTACs的疗效。
ACS Pharmacol Transl Sci. 2024 Dec 16;8(1):21-35. doi: 10.1021/acsptsci.4c00408. eCollection 2025 Jan 10.
2
Proteasome regulators in pancreatic cancer.胰腺癌中的蛋白酶体调节剂
World J Gastrointest Oncol. 2022 Jan 15;14(1):38-54. doi: 10.4251/wjgo.v14.i1.38.
3
Advances in Proteasome Enhancement by Small Molecules.小分子增强蛋白酶体的研究进展。
Biomolecules. 2021 Nov 30;11(12):1789. doi: 10.3390/biom11121789.
4
Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.天然产物骨架作为设计和合成20S人蛋白酶体抑制剂的灵感来源。
RSC Chem Biol. 2020 Dec 1;1(5):305-332. doi: 10.1039/d0cb00111b. Epub 2020 Sep 16.
5
Pharmacological intervention in a transgenic mouse model improves Alzheimer's-associated pathological phenotype: Involvement of proteasome activation.药物干预转基因小鼠模型改善阿尔茨海默病相关病理表型:涉及蛋白酶体激活。
Free Radic Biol Med. 2021 Jan;162:88-103. doi: 10.1016/j.freeradbiomed.2020.11.038. Epub 2020 Dec 3.
6
Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.蛋白酶体抑制剂:利用蛋白质稳态来对抗疾病。
Molecules. 2020 Feb 5;25(3):671. doi: 10.3390/molecules25030671.
7
Microbial Proteases Applications.微生物蛋白酶的应用
Front Bioeng Biotechnol. 2019 Jun 12;7:110. doi: 10.3389/fbioe.2019.00110. eCollection 2019.
8
A Practical Review of Proteasome Pharmacology.蛋白酶体药理学实用综述。
Pharmacol Rev. 2019 Apr;71(2):170-197. doi: 10.1124/pr.117.015370.
9
Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.蛋白酶体激活作为靶向蛋白毒性疾病的新治疗方法。
J Med Chem. 2019 Jul 25;62(14):6469-6481. doi: 10.1021/acs.jmedchem.9b00101. Epub 2019 Mar 14.
10
High-resolution cryo-EM proteasome structures in drug development.高分辨率冷冻电镜蛋白酶体结构在药物研发中的应用。
Acta Crystallogr D Struct Biol. 2017 Jun 1;73(Pt 6):522-533. doi: 10.1107/S2059798317007021. Epub 2017 May 31.